Host: |
HEK293 cells |
Reactivity: |
Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Recombinant-Mouse VCAM-1/CD106-C-hFc&His protein was developed from hek293 cells and has a target region of C-hFc&His. For use in research applications. |
Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. Contact us for customized product form or formulation. |
Immunoreactivity: |
Measured by the ability of the immobilized protein to support the adhesion of U937 human histiocytic lymphoma cells. When 5 x 10E4 cells/well are added to mouse VCAM1 coated plates (10 Mu g/mL with 100 Mu L/well) , approximately 80%-90% cells will ad |
Immunogen: |
Recombinant Mouse VCAM-1/CD106 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Met1-Glu698) of mouse VCAM-1/CD106 (Accession #NP_035823.3) fused with a Fc, 6×His tag at the C-terminus. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance